UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q2 2022 | 2022-08-08 | Future report Set alerts | |
| Q1 2022 | 2022-05-06 | -0.09 | -0.09 |
| Q4 2021 | 2022-03-15 | -0.09 | -0.09 |
| Q3 2021 | 2021-11-15 | -0.07 | -0.07 |
| Q2 2021 | 2021-08-09 | -0.10 | -0.10 |
| Q1 2021 | 2021-05-06 | -0.13 | -0.13 |
| Q4 2020 | 2021-03-25 | -0.11 | -0.11 |
| Q3 2020 | 2020-11-09 | -0.11 | 0.00 |
| Q2 2020 | 2020-08-10 | -0.10 | -0.10 |
| Q1 2020 | 2020-05-07 | -0.10 | -0.10 |
| 2016-06-27 | Reiterated Rating | Maxim Group | Buy | |
| 2016-05-08 | Reiterated Rating | Maxim Group | Buy | |
| 2016-03-11 | Reiterated Rating | Maxim Group | Buy | $5.00 to $10.00 |
| 2016-02-21 | Reiterated Rating | Maxim Group | Buy | $5.00 |
| 2016-01-10 | Reiterated Rating | WBB Securities | Buy | $9.00 |
| 2015-12-28 | Reiterated Rating | Maxim Group | Buy | |
| 2015-12-22 | Reiterated Rating | Maxim Group | Buy | $9.00 to $5.00 |
| 2015-07-10 | Downgrade | Piper Jaffray | Overweight to Hold | |
| 2015-07-10 | Downgrade | Piper Jaffray Cos. | Overweight to Hold | |
| 2015-07-09 | Downgrade | Piper Jaffray | Overweight to Neutral | $1.00 |
| 2015-01-23 | Boost Price Target | Maxim Group | Buy | $7.00 to $9.00 |
| 2014-12-29 | Set Price Target | Maxim Group | Buy | $7.00 |
| 2014-05-06 | Reiterated Rating | Edison Investment Research | Neutral to Neutral | |
| 2014-04-29 | Initiated Coverage | First Analysis | Overweight | $5.00 |
| 2014-04-28 | Reiterated | Maxim Group | Buy | $10 to $7 |
| 2013-12-19 | Boost Price Target | Maxim Group | Buy | $6.00 to $10.00 |
| 2012-10-05 | Reiterated | Maxim Group | Buy | $3 to $6 |
| 2010-09-13 | Reiterated | WBB Securities | Strong Buy | $8 to $9 |
| 2010-07-30 | Upgrade | WBB Securities | Buy to Strong Buy | $8 |
| 2010-04-12 | Initiated | Brean Murray | Buy | $8 |
| 2008-11-11 | Reiterated | Leerink Swann | Outperform | $8 to $4 |
| 2008-09-17 | Initiated | Leerink Swann | Outperform | $8 |
| 2008-08-01 | Initiated | Canaccord Adams | Buy | $6 |
| 2008-06-19 | Initiated | Lazard Capital | Buy | $7 |
| 2008-06-02 | Initiated | Cowen & Co | Outperform |
| 2016-06-27 | Reiterated Rating | Maxim Group | Buy | |
| 2016-05-08 | Reiterated Rating | Maxim Group | Buy | |
| 2016-03-11 | Reiterated Rating | Maxim Group | Buy | $5.00 to $10.00 |
| 2016-02-21 | Reiterated Rating | Maxim Group | Buy | $5.00 |
| 2016-01-10 | Reiterated Rating | WBB Securities | Buy | $9.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ATHX 0 funds of 2220 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Van Bokkelen Gil Chmn & Chief Executive Officer | 1.58% (1221219) | ATHX / |
| Harrington John J Dir. & Chief Scientific Off. | 0.80% (620003) | ATHX / |
| Campbell Laura K Vice President | 0.73% (561809) | ATHX / |
| Lehmann William JR President & COO | 0.61% (467973) | ATHX / |
| Deans Robert J Sr. Vice President | 0.55% (426639) | ATHX / |
| Davis Jordan | 0.35% (273520) | ATHX / TCMD / |
| TRAUB KENNETH H | 0.10% (80000) | ATHX / CAS / DSPG / GLF / IMI / IPAS / MRVC / VTSS / |
| ORBIMED ADVISORS LLC | 0.02% (15250) | AGLE / AMBI / ANTH / ATHX / BOLD / BONE / CRVS / CTIC / ICPT / KALA / LOXO / MRTX / OTIC / RLYP / ROKA / SIEN / SUPN / SYBX / XLRN / |
| Kola Ismail | 0.02% (15000) | ATHX / |
| SHEFFERY MICHAEL B | 0.01% (3872) | ATHX / SUPN / |
UM